Table 3.
Control subjects (n = 10) | PKU subjects (n = 12) | p | |
---|---|---|---|
∆ HR (beats/min) | 20 (15–24) | 16 (12.2–25.2) | 0.491 |
∆ Systolic BP (mmHg) | 23.5 (7.7–48.2) | 36.5 (19–43.5) | 0.261 |
∆ Diastolic BP (mmHg) | 18 (10–40) | 13.5 (4.7–19.5) | 0.371 |
∆ Phe (μmol/L) | 2.7 (− 1.3 – 5.9) | 11.1 (−33.5–37) | 0.242 |
∆ Tyr (μmol/L) | 0.4 (− 5.5–3.1) | − 1.4 (− 8.2–0.9) | 0.645 |
∆ NE (pg/ml) | 61.2 (34.0–209.5) | 40.6 (17.7–98.8) | 0.999 |
∆ E (pg/ml) | 14.5 (5.4–53.5) | 14.2 (4.9–27.6) | 0.541 |
Values are presented as median (25th and 75th percentiles)
Abbreviations: ∆ change from resting, HR heart rate, BP blood pressure, Phe phenylalanine, Tyr Tyrosine, NE norepinephrine, E epinephrine